Consistent with our results, Hsu et al. [26], performed ChIP-seq using an anti-MYCN antibody in the MYCN-amplified neuroblastoma cell BE(2)C, demonstrated that TFAP4 is a direct transcriptional MYCN target. This evidence concerns the gene TFAP4 and neuroblastoma.